Your Custom Text Here
Ben Isbel, from the Sunshine Coast Mind and Neuroscience Thompson Institute at the University of the Sunshine Coast, is overseeing the world-first study.
Mr Isbel said the study assessed whether attention training programs improved cognitive function, such as attention and memory — specifically in healthy, older adults.
"There have been quite a few studies using the kind of technology we are using but realistically, they've all been done on a younger population," he said.
Rising minimum wage levels have come to the forefront of American politics this year, with the Fight for $15 per hour taking center stage across numerous industries. Home care workers are one of those industries where on-the-ground activism has led to a big payoff—but only in some areas of the country.
For the vast majority of Americans working minimum and low-wage jobs, not much has changed. It’s a topic I report on often, but I haven’t had the opportunity to see what home care wages really look like, until I recently viewed a documentary focusing on the home care workers’ perspective. As home care workers continue to band together to push for higher wages, a recently released documentary portrays the lives and hardships of caregivers who take care of seniors at home.
Our understanding of diseases often follows a predictable journey. First, we begin to understand that a group of symptoms occur together. For example, we know that a sore throat can occur with cough and fever. Next, we learn to split hairs, separating disorders that appear similar but have different causes and courses. The sore throat with fever, cough, difficulty swallowing, and white spots on the tonsils is not like the one that doesn’t have these extra features. We often learn about the disease’s course before we know what causes the disease. In the case of the more severe sore throat, its potential for leaving serious heart damage was understood before its cause, strep infection, was made possible by advances in diagnostic techniques. Once a cause is known, researchers may be able to design a specific treatment, but not always. We know the antibiotics that are likely to defeat strep throat, but we still have no cure for the more common viral sore throat.
AFTER Mark Donham’s wife, Chris, fell under the spell of early-onset Alzheimer’s, he doubled down on his marriage vows. He quit his job as a well-paid sales representative in the printing industry and became his wife’s 24-hour caregiver: dressing her, doing laundry and scheduling social visits with friends. Faith, hope and courage became his new mantra.
As Alzheimer’s slowly progressed and Chris became frailer, their lives narrowed. To explain their painful emotional journey to friends and family, Mr. Donham, who lives in Portland, Ore., began making videos and posting them on YouTube.
The first drug that can prevent Alzheimer’s disease is finally on the horizon after scientists proved they can clear the sticky plaques from the brain which cause dementia and halt mental decline.
Hailed as the "best news" in dementia research for 25 years, the breakthrough is said to be a potential "game changer" for people with Alzheimer’s.
An experimental drug called aducanumab shows promise in treating Alzheimer's disease, researchers report.
A small clinical trial showed that it significantly reduced toxic plaques in the brains of 165 patients with early-stage Alzheimer's disease, National Public Radio reported Wednesday.
The findings, published in the journal Nature, suggest the drug may slow the loss of memory and thinking in Alzheimer's patients.
Catherine Serie was announced today as the new Chief Operating Officer(COO) of the Chicago based organization, which is dedicated to quality training to care for today's senior adults as well as the overall improvement of the senior living lifestyle. As the Chief Operating Officer, Serie will be responsible for marketing and development of new education programs, certifications and managing the day to day business of the organization.
Many people today are faced with the difficult task of caring for an aging parent. The National Alliance for Caregiving reported that 36 percent of the 65 million unpaid caregivers in the U.S. are caring for an aging parent. This challenging role reversal leaves current and future caregivers asking a difficult question: How do you prepare for becoming your parents’ caregiver?
As you do prepare for caregiving duties, it is important to explore your own abilities and what you will realistically be able to do for your parents. In order to avoid becoming overwhelmed with stress, you should consider what life would be like for you as a caregiver.
Some older women who take calcium supplements may face an increased risk of developing dementia, a small study suggests.
The heightened risk appears limited to women who have had a stroke or suffer from disorders that affect blood flow to the brain, researchers report in the journal Neurology.
“Our study is the first to show a relationship between calcium supplementation and increased risk for dementia in older women,” said lead author Silke Kern of the University of Gothenburg in Sweden.
A study by researchers at UCLA’s Semel Institute for Neuroscience and Human Behavior has found that a healthy diet, regular physical activity and a normal body mass index can reduce the incidence of protein build-ups that are associated with the onset of Alzheimer’s disease.
In the study, 44 adults ranging in age from 40 to 85 (mean age: 62.6) with mild memory changes but no dementia underwent an experimental type of PET scan to measure the level of plaque and tangles in the brain. Researchers also collected information on participants’ body mass index, levels of physical activity, diet and other lifestyle factors. Plaque, deposits of a toxic protein called beta-amyloid in the spaces between nerve cells in the brain; and tangles, knotted threads of the tau protein found within brain cells, are considered the key indicators of Alzheimer’s.
Read any article about Alzheimer's and you'll think the next cure for this devastating disease is right around the corner. But for patients and their families, the stark reality is that it's been more than a decade since memantine, the last molecule against Alzheimer's, was approved in Europe and the US.
Since then, there has been a number of trials for different drugs, but none have been successful. The drugs that do exist are not intended to cure Alzheimer's sufferers – they are only able to attenuate the symptoms and slow down the disease's progression.
A new low-cost biochip-based blood test which can test for an increased risk of Alzheimer's disease.